APT Medical Inc. (SHA:688617)

APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,392	2,049	1,642	1,204	822.86	477.94
Other Revenue	16.62	16.62	8.49	11.55	5.82	1.5
Revenue	2,408	2,066	1,650	1,216	828.69	479.44
Revenue Growth (YoY)	22.80%	25.18%	35.71%	46.74%	72.85%	18.68%
Cost of Revenue	664.14	579.89	486.14	354.04	259.08	142.13
Gross Profit	1,744	1,486	1,164	861.98	569.61	337.3
Selling, General & Admin	546.23	464.34	386.96	307.57	251.43	152.5
Research & Development	342.83	290.54	237.92	174.88	134.88	71.9
Other Operating Expenses	19.73	15.22	14.52	13.75	8.14	6.14
Operating Expenses	911.17	772.32	639.21	496.99	393.93	230.82
Operating Income	833.1	713.59	524.86	364.99	175.68	106.48
Interest Expense	-1.41	-2.01	-3.69	-1.45	-1.63	-0.83
Interest & Investment Income	28.49	25.23	27.74	23.94	13.26	1.21
Currency Exchange Gain (Loss)	2.83	2.83	2.66	1.17	-1	-0.43
Other Non Operating Income (Expenses)	3.29	-0.82	-0.04	-0.49	-0.5	-0.33
EBT Excluding Unusual Items	866.29	738.83	551.53	388.16	185.81	106.09
Impairment of Goodwill	-	-	-3.84	-	-	-
Gain (Loss) on Sale of Investments	-17.5	-16.7	-	0.34	21.72	-0.07
Gain (Loss) on Sale of Assets	-0.92	0.25	11.97	0.06	0.02	-0.23
Asset Writedown	-2.63	-0.83	-0.12	-10.68	-3.57	-
Other Unusual Items	19.71	24.42	36.83	17.25	17.58	15.42
Pretax Income	864.95	745.97	596.37	395.13	221.55	121.21
Income Tax Expense	114.02	87.8	74.24	54.98	26.7	17.02
Earnings From Continuing Operations	750.94	658.17	522.13	340.16	194.85	104.19
Minority Interest in Earnings	17.37	14.98	11.79	17.86	13.07	6.58
Net Income	768.31	673.15	533.92	358.02	207.92	110.78
Net Income to Common	768.31	673.15	533.92	358.02	207.92	110.78
Net Income Growth	16.62%	26.08%	49.13%	72.19%	87.70%	34.15%
Shares Outstanding (Basic)	141	140	140	140	137	105
Shares Outstanding (Diluted)	141	141	142	142	138	105
Shares Change (YoY)	-0.09%	-0.52%	-0.16%	2.99%	31.45%	-0.29%
EPS (Basic)	5.45	4.80	3.82	2.56	1.52	1.06
EPS (Diluted)	5.44	4.77	3.77	2.52	1.51	1.06
EPS Growth	16.72%	26.74%	49.38%	67.20%	42.79%	34.54%
Free Cash Flow	569.8	93.15	487.03	224.25	14.01	104.04
Free Cash Flow Per Share	4.04	0.66	3.44	1.58	0.10	0.99
Dividend Per Share	1.207	1.207	0.951	0.785	0.476	0.238
Dividend Growth	26.88%	26.88%	21.20%	65.01%	100.00%	-
Gross Margin	72.42%	71.93%	70.54%	70.88%	68.74%	70.35%
Operating Margin	34.59%	34.54%	31.81%	30.01%	21.20%	22.21%
Profit Margin	31.90%	32.58%	32.36%	29.44%	25.09%	23.11%
Free Cash Flow Margin	23.66%	4.51%	29.51%	18.44%	1.69%	21.70%
EBITDA	925.22	790.25	580.9	405.69	203.49	126.49
EBITDA Margin	38.42%	38.25%	35.20%	33.36%	24.56%	26.38%
D&A For EBITDA	92.12	76.66	56.04	40.7	27.81	20
EBIT	833.1	713.59	524.86	364.99	175.68	106.48
EBIT Margin	34.59%	34.54%	31.80%	30.01%	21.20%	22.21%
Effective Tax Rate	13.18%	11.77%	12.45%	13.91%	12.05%	14.04%
Revenue as Reported	2,408	2,066	1,650	1,216	828.69	479.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.